tiprankstipranks

Kinney Horn Insider Profile

4 Followers
Kinney Horn, CBO at Immunome, holds 0.00 shares in Immunome (Ticker: IMNM), holds 2.46K shares in Olema Pharmaceuticals (Ticker: OLMA).
tipranks
Kinney Horn

Kinney Horn
Immunome (IMNM)
CBO

Not Ranked
Kinney Horn has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$25K
100.00%
0.00%
A breakdown of Kinney Horn's holdings

Insider Roles

Olema Pharmaceuticals
(OLMA)
CBO
Immunome
(IMNM)
CBO
Roles that Kinney Horn holds in companies

Most Profitable Insider Trade

Currently, no data available
The most profitable trade made by Kinney Horn

Kinney Horn's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Immunome
Aug 06, 2026
CBO
Uninformative Buy
1.08M
$0.00
Olema Pharmaceuticals
Mar 14, 2022
CBO
Uninformative Buy
10.82K
$25.46K
List of latest transactions for each holding click on a transaction to see Kinney Horn's performance on stock

Kinney Horn insider profile FAQ

What is the percentage of profitable transactions made by Kinney Horn?
The percentage of profitable transactions made by Kinney Horn is ―.
    What is the average return per transaction made by Kinney Horn?
    The average return per transaction made by Kinney Horn is ―.
      What stocks does Kinney Horn hold?
      Kinney Horn holds: IMNM, OLMA stocks.
        What was Kinney Horn’s latest transaction?
        Kinney Horn latest transaction was an Uninformative Buy of $1.08M.
          What was Kinney Horn's most profitable transaction?
          Kinney Horn’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
            What is Kinney Horn's role in Immunome?
            Kinney Horn's role in Immunome is CBO.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.